Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Sep 6 - Sep 11
This acquisition is aimed at enhancing its portfolio with the addition of Metsera's Next-Generation Obesity Portfolio
To illustrate, a recent study of 23,000 people on semaglutide-based products across multiple payer types did not find a decline in medical spending for those who were prescribed the medications
VCP services will be covered at the cost share amount that would apply to non-VCPs
Wake up
Due to safety concerns, medications for weight loss therapy are not recommended for patients who are breastfeeding. If youre interested in discussing these risks further with a healthcare professional, just complete a short online assessment
Our primary focus at TrimrX is on medically-supervised weight loss
US$ 24.24
US$ 24.89
US$ 27.72
US$ 29.64
US$ 23.44
